DIM (3,3′-diindolylmethane) confers protection against ionizing radiation by a unique mechanism

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 46, 2013, Pages 18650-18655

  Fan, Saijun ^a,b,c   Meng, Qinghui ^a   Xu, Jiaying ^b   Jiao, Yang ^b   Zhao, Lin ^b   Zhang, Xiaodong ^c   Sarkar, Fazlul H ^d   Brown, Milton L ^a   Dritschilo, Anatoly ^a   Rosen, Eliot M ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^c INSTITUTE OF RADIATION MEDICINE   (China)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,3' DIINDOLYLMETHANE; ATM PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; IONIZING RADIATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIATION DOSE; RADIATION INJURY; RADIATION PROTECTION; RADIATION RESPONSE; RAT; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; WHOLE BODY RADIATION;

ANIMALS; APOPTOSIS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; BLOTTING, WESTERN; CELL LINE; COMET ASSAY; ENZYME ACTIVATION; FEMALE; GREEN FLUORESCENT PROTEINS; IMMUNOPRECIPITATION; INDOLES; KAPLAN-MEIER ESTIMATE; LUCIFERASES; MICE; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; RADIATION INJURIES, EXPERIMENTAL; RADIATION, IONIZING; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING;

EID: 84887501503     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1308206110     Document Type: Article

References (52)

1. Verhoeven DT, Goldbohm RA, van Poppel G, Verhagen H, van den Brandt PA (1996) Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev 5(9):733-748. (Pubitemid 26304649)
2. Higdon JV, Delage B, Williams DE, Dashwood RH (2007) Cruciferous vegetables and human cancer risk: Epidemiologic evidence and mechanistic basis. Pharmacol Res 55(3):224-236. (Pubitemid 46518152)
3. Bradlow HL, Michnovicz J, Telang NT, Osborne MP (1991) Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12(9):1571-1574.
4. Kojima T, Tanaka T, Mori H (1994) Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res 54(6): 1446-1449. (Pubitemid 24106404)
5. Jin L, et al. (1999) Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice. Cancer Res 59(16):3991-3997. (Pubitemid 29393567)
6. Aggarwal BB, Ichikawa H (2005) Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 4(9):1201-1215. (Pubitemid 41365390)
7. Anderton MJ, et al. (2004) Physiological modeling of formulated and crystalline 3,3′-diindolylmethane pharmacokinetics following oral administration in mice. Drug Metab Dispos 32(6):632-638. (Pubitemid 38668156)
8. Anderton MJ, et al. (2004) Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice. Clin Cancer Res 10(15):5233-5241. (Pubitemid 39099798)
9. Reed GA, et al. (2006) Single-dose and multiple-dose administration of indole-3-carbinol to women: Pharmacokinetics based on 3,3′- diindolylmethane. Cancer Epidemiol Biomarkers Prev 15(12):2477-2481. (Pubitemid 46048308)
10. Reed GA, et al. (2008) Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3′-diindolylmethane in healthy subjects. Cancer Epidemiol Biomarkers Prev 17(10):2619-2624.
11. Heath EI, et al. (2010) A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3′-Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. Am J Transl Res 2(4):402-411.
12. Del Priore G, et al. (2010) Oral diindolylmethane (DIM): Pilot evaluation of a nonsurgical treatment for cervical dysplasia. Gynecol Oncol 116(3):464-467.
13. Kong D, et al. (2008) Mammalian target of rapamycin repression by 3,3′-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells. Cancer Res 68(6):1927-1934. (Pubitemid 351416579)
14. Li Y, et al. (2007) Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3′- diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J Biol Chem 282(29):21542-21550. (Pubitemid 47099972)
15. Garikapaty VP, Ashok BT, Tadi K, Mittelman A, Tiwari RK (2006) 3,3′-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer. Biochem Biophys Res Commun 340(2):718-725. (Pubitemid 43021805)
16. Firestone GL, Bjeldanes LF (2003) Indole-3-carbinol and 3-3′-diindolylmethane anti-proliferative signaling pathways control cell-cycle gene transcription in human breast cancer cells by regulating promoter-Sp1 transcription factor interactions. J Nutr 133(7, Suppl):2448S-2455S.
17. Firestone GL, Sundar SN (2009) Minireview: Modulation of hormone receptor signaling by dietary anticancer indoles. Mol Endocrinol 23(12):1940-1947.
18. Mulvey L, et al. (2007) Interplay of genes regulated by estrogen and diindolylmethane in breast cancer cell lines. Mol Med 13(1-2):69-78. (Pubitemid 46786835)
19. Carter TH, et al. (2002) Diindolylmethane alters gene expression in human keratinocytes in vitro. J Nutr 132(11):3314-3324. (Pubitemid 35304238)
20. Meng Q, et al. (2000) Indole-3-carbinol is a negative regulator of estrogen receptoralpha signaling in human tumor cells. J Nutr 130(12):2927-2931. (Pubitemid 32005319)
21. Sun S, et al. (2004) Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro. Cell Stress Chaperones 9(1): 76-87.
22. Fan S, Meng Q, Auborn K, Carter T, Rosen EM (2006) BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer 94(3):407-426. (Pubitemid 43237565)
23. Dalessandri KM, Firestone GL, Fitch MD, Bradlow HL, Bjeldanes LF (2004) Pilot study: Effect of 3,3′-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutr Cancer 50(2):161-167.
24. Le HT, Schaldach CM, Firestone GL, Bjeldanes LF (2003) Plant-derived 3,3′-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J Biol Chem 278(23):21136-21145. (Pubitemid 36806427)
25. Fan S, Meng Q, Saha T, Sarkar FH, Rosen EM (2009) Low concentrations of diindolylmethane, a metabolite of indole-3-carbinol, protect against oxidative stress in a BRCA1-dependent manner. Cancer Res 69(15):6083-6091.
26. Kitagawa R, Kastan MB (2005) The ATM-dependent DNA damage signaling pathway. Cold Spring Harb Symp Quant Biol 70:99-109. (Pubitemid 44124861)
27. Lee JH, Paull TT (2007) Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene 26(56):7741-7748.
28. Thompson JS, Chu Y, Glass J, Tapp AA, Brown SA (2010) The manganese superoxide dismutase mimetic, M40403, protects adult mice from lethal total body irradiation. Free Radic Res 44(5):529-540.
29. Epperly MW, et al. (2011) Antioxidant-chemoprevention diet ameliorates late effects of total-body irradiation and supplements radioprotection by MnSOD-plasmid liposome administration. Radiat Res 175(6):759-765.
30. Cucinotta FA, Pluth JM, Anderson JA, Harper JV, O'Neill P (2008) Biochemical kinetics model of DSB repair and induction of γ-H2AX foci by non-homologous end joining. Radiat Res 169(2):214-222. (Pubitemid 351295079)
31. Jakob B, et al. (2011) DNA double-strand breaks in heterochromatin elicit fast repair protein recruitment, histone H2AX phosphorylation and relocation to euchromatin. Nucleic Acids Res 39(15):6489-6499.
32. Zhang Y, Jung M, Dritschilo A, Jung M (2004) Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors. Radiat Res 161(6): 667-674. (Pubitemid 39149575)
33. Hickson I, et al. (2004) Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res 64(24): 9152-9159. (Pubitemid 39665530)
34. Liu Q, et al. (2000) Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev 14(12):1448-1459. (Pubitemid 30421838)
35. Lee JH, Paull TT (2005) ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 308(5721):551-554.
36. Taylor AM, Groom A, Byrd PJ (2004) Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis. DNA Repair (Amst) 3(8-9):1219-1225. (Pubitemid 38997965)
37. Martin FL, et al. (1997) DNA damage in breast epithelial cells: Detection by the singlecell gel (comet) assay and induction by human mammary lipid extracts. Carcinogenesis 18(12):2299-2305. (Pubitemid 28134641)
38. Lee SJ, Dimtchev A, Lavin MF, Dritschilo A, Jung M (1998) A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-kappaB. Oncogene 17(14):1821-1826. (Pubitemid 28482785)
39. Goodarzi AA, et al. (2004) Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A. EMBO J 23(22):4451-4461. (Pubitemid 39601970)
40. Jeggo PA, Löbrich M (2005) Artemis links ATM to double strand break rejoining. Cell Cycle 4(3):359-362.
41. Goodarzi AA, Jeggo P, Lobrich M (2010) The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax. DNA Repair (Amst) 9(12):1273-1282.
42. Iliakis G, et al. (2004) Mechanisms of DNA double strand break repair and chromosome aberration formation. Cytogenet Genome Res 104(1-4):14-20. (Pubitemid 38721048)
43. Bae I, et al. (2004) BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res 64(21):7893-7909. (Pubitemid 39446923)
44. Saha T, Rih JK, Roy R, Ballal R, Rosen EM (2010) Transcriptional regulation of the base excision repair pathway by BRCA1. J Biol Chem 285(25):19092-19105.
45. Barzilai A, Rotman G, Shiloh Y (2002) ATM deficiency and oxidative stress: A new dimension of defective response to DNA damage. DNA Repair (Amst) 1(1):3-25. (Pubitemid 34475690)
46. Watters DJ (2003) Oxidative stress in ataxia telangiectasia. Redox Rep 8(1):23-29.
47. Reliene R, Schiestl RH (2007) Antioxidants suppress lymphoma and increase longevity in Atm-deficient mice. J Nutr 137(1, Suppl):229S-232S. (Pubitemid 46074948)
48. Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT (2010) ATM activation by oxidative stress. Science 330(6003):517-521.
49. Krüger A, Ralser M (2011) ATM is a redox sensor linking genome stability and carbon metabolism. Sci Signal 4(167):pe17.
50. Chang X, et al. (2005) 3,3′-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis 26(4): 771-778. (Pubitemid 41214339)
51. Nachshon-Kedmi M, Fares FA, Yannai S (2004) Therapeutic activity of 3,3′-diindolylmethane on prostate cancer in an in vivo model. Prostate 61(2):153-160. (Pubitemid 39244702)
52. Fares F, Azzam N, Appel B, Fares B, Stein A (2010) The potential efficacy of 3,3′- diindolylmethane in prevention of prostate cancer development. Eur J Cancer Prev 19(3):199-203.